Yang Y, Feng DX, Wang Y. Application of dexmedetomidine combined with ultrasound-guided transverse abdominal fascia block during radical colorectal cancer surgery under general anesthesia.
Shijie Huaren Xiaohua Zazhi 2023;
31:418-425. [DOI:
10.11569/wcjd.v31.i10.418]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 05/26/2023] Open
Abstract
BACKGROUND
Radical surgery is the main treatment for colorectal cancer, and effective anaesthesia is required in the perioperative period to ensure a smooth operation. Dexmedetomidine is a commonly used anaesthetic drug, but the optimal dose for general anaesthesia in radical colorectal cancer surgery is still unknown.
AIM
To investigate the application of different doses of dexmede-tomidine combined with ultrasound-guided transverse abdominal fascial block in radical colorectal cancer surgery under general anesthesia.
METHODS
Two hundred patients proposed for radical colorectal cancer surgery under general anesthesia at our hospital from October 2017 to September 2022 were selected and divided into three groups (A, B, and C) using the random number table method. Sixty-seven patients in group A were given 0.5 μg/kg dexmedetomidine, 67 patients in group B were given 0.25 μg/kg dexmedetomidine, and 66 patients in group C were given an equal dose of saline. The vital signs [heart rate (HR), oxygen saturation (SaO2), and mean arterial pressure (MAP)] before induction of anesthesia (T0), after dexmedetomidine injection (T1), 1 h after the start of surgery (T2), and immediately after the end of surgery (T3), the visual analog scale (VAS) scores at 6 h, 12 h, and 24 h after surgery, the number of analgesic pump compressions at 24 h after surgery, the number of times of remedial analgesia, the levels of immune cytokines [tumor necrosis factor-α (TNF-α), interleukin-2 (IL-2), and interleukin-10 (IL-10)], serum neurotransmitter [serum S100B protein (S100B), serum neuron-specific enolase (NSE), and serum brain-derived neurotrophic factor (BDNF)] before surgery and 12 h and 24 h after surgery, and adverse effects were recorded.
RESULTS
There was no statistically significant difference in SaO2 among the three groups from T0 to T3 (P > 0.05), and HR and MAP at T1 and T2 were lower in group A than in groups B and C, and in group B than in group C (P < 0.05). VAS scores in group A were lower than those in groups B and C at 6 h, 12 h, and 24 h postoperatively, and the number of analgesic pump compressions and times of remedial analgesia at 24 h postoperatively were less in group A than in groups B and C (P < 0.05), and in group B than in group C (P < 0.05). Serum TNF-α and IL-10 at 12 h and 24 h postoperatively were lower in group A than in groups B and C, and IL-2 was higher than in groups B and C; these indexes in group B were superior to those in group C (P < 0.05). Serum S100B and NSE at 12 h postoperatively were lower in group A than in groups B and C, and BDNF was higher than in groups B and C; these indexes in group B were superior to those in group C (P < 0.05). The differences in the incidence of adverse reactions were not statistically significant among the three groups (P > 0.05).
CONCLUSION
Compared with 0.25 μg/kg dexmedetomidine, 0.5 μg/kg dexmedetomidine combined with ultrasound-guided transverse abdominal fascial block for radical colorectal cancer surgery under general anesthesia can more effectively maintain the stability of patients' vital signs, with less impact on patients' immune function and neurological function, and better postoperative analgesia without increasing the risk of adverse effects.
Collapse